Filing Details
- Accession Number:
- 0001562180-19-004830
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-16 18:36:02
- Reporting Period:
- 2019-09-12
- Accepted Time:
- 2019-09-16 18:36:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1690585 | Magenta Therapeutics Inc. | MGTA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1741288 | P. Michael Cooke | C/O Magenta Therapeutics, Inc. 100 Technology Square, 5Th Floor Cambridge MA 02139 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-09-12 | 844 | $12.00 | 264,679 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This trade is pursuant to an active 10b5-1 plan.
Billionaire Hedge Funds
